GLP-1 drugs like Ozempic set to shake the global food industry
Originally intended as a treatment for diabetes, GLP-1 drugs like Ozempic could be set to turn the food and drink industry upside down.
News & Analysis on Food & Beverage Development & Technology
Originally intended as a treatment for diabetes, GLP-1 drugs like Ozempic could be set to turn the food and drink industry upside down.
Plant-based diets remain popular, but associations with UPF and low-quality ingredients has shaken consumer trust in alt meat, fish and dairy brands. So, what can the sector do to restore public opinion?
Chocolate leader Tony’s Chocolonely raises concerns about the European Commission’s decision to postpone the EUDR implementation date by 12 months.